{"line_no":1,"decision":"edit","rationale":"Rebuilt SCD intro into mechanism-first framework with electrophoresis and VOC-vs-osteomyelitis comparison table.","input_sha256":"92c8e9256aa77a4aa686549eac8a448c08b41b79ee14abd5a756784c15ded6a0","output_sha256":"64973957712b0f716c86b3096f3e383602e4b01ed815f5e8dee55f33ccabbeb4"}
{"line_no":2,"decision":"edit","rationale":"Preserved acute crisis logic (ACS/sequestration/aplastic/stroke) with explicit reticulocyte trap differentiation.","input_sha256":"c8285335bafa1891a5cf5c2132a3e88464e1845406732d0ecdec343e0f8ee1fc","output_sha256":"dc84260177c814f2243840b04bb6700bec9d62975889f6e4e7259ac7f408b61d"}
{"line_no":3,"decision":"edit","rationale":"Condensed chronic complications, maintenance, pregnancy risks, and high-yield scenario recap; removed transition chatter.","input_sha256":"3636836bf1407300e91b91d9bb727b5db72c36fef93e488c15d4653ffaa55349","output_sha256":"c1de16abf5607ee6d6bd0fd8dd5c9b40c37d69177e829bbe5edf4b98f6f85ab5"}
{"line_no":4,"decision":"edit","rationale":"Converted mixed narrative to structured hemolysis/porphyria top-down map and HS diagnostic-treatment essentials.","input_sha256":"d129b244f3fa68195f9c4447e0d426bff4a8207472efe008ec7a209091a47b50","output_sha256":"dd68f0ab59a0e3c7816d1808150190b8a9c22070f43c03cf3f4a3942c19901f0"}
{"line_no":5,"decision":"edit","rationale":"Retained macroangiopathic valve hemolysis and AIP mechanism/trigger/treatment sequence.","input_sha256":"a51b03948efd51c171c2e96daf41897b5f64a0b4b4032cc137f66987c310ef31","output_sha256":"b635127a9837c63e2272b9b8ec98f275687b06c4f21c4917391950a3c68108e8"}
{"line_no":6,"decision":"edit","rationale":"Kept AIP-vs-lead differential table and scenario quiz points in concise exam format.","input_sha256":"1f69a615e4230db0874477ae1f7ef4c96639b455365deab687b1b15558a52404","output_sha256":"d947857972011ffabfbb45e735ec2899b0bfe388a79c04076eca5c35a619ca22"}
{"line_no":7,"decision":"edit","rationale":"Reframed leukemia section into acute-vs-chronic architecture and pediatric acute doorway logic.","input_sha256":"0f7f472f26b47c31a9f74ad81498346b3db85bd3bbcae427ea8931d06423326d","output_sha256":"3c5899912dc438332ef873d22caecff3893fd9c47045c240ed9f71896d46f07a"}
{"line_no":8,"decision":"edit","rationale":"Maintained entity-level distinctions for ALL/CML/CLL/hairy cell with core diagnostics and therapies, preserving tabular structure.","input_sha256":"3c39d78c8a6c5fbded212037be0f1593cd253ba868d63cc8ab5fa13949bd812e","output_sha256":"2a42017d2a5910f4b0b2c40522f08a3f6e390c19218ea610681790ffb6d9d1cf"}
{"line_no":9,"decision":"edit","rationale":"Recap normalized and transition content kept only as clinically relevant framework bridge.","input_sha256":"c07d75794ab8bce7afe6462310f4f7f2d4b08ecf83800631c1b79f15ec528f7b","output_sha256":"c400eb6a3e076fe5ecba1177af7f4d057a43517809711dc4bc941a3b81524814"}
{"line_no":10,"decision":"edit","rationale":"Preserved Hodgkin survivorship timeline and MM-vs-WM pathophysiology comparison.","input_sha256":"dc67553329c88e9d8ec7171b1ce175eda87a608dae318207de119402758d5a1f","output_sha256":"55ee5d9dfcea46524985e8a615b72cc3078302d0051060f34ffeeea6e5bda733"}
{"line_no":11,"decision":"edit","rationale":"Focused on WM hyperviscosity and critical myeloma imaging trap with correct modality choice.","input_sha256":"b39cd55436488695f125ec9e8c243b6a54fb541b9350a83ae38b6271256ad49f","output_sha256":"add3d26e2fd3a1d553a78070f46048fb4a14819bdbf46373a911014bb8dc4da2"}
{"line_no":12,"decision":"edit","rationale":"Converted noisy recap/reflection text into strict high-yield summary table and removed non-learning narration.","input_sha256":"5755d1b45af24cb91c333691c0a1ecc2e7b0aef3b4000b2d49e0694fca823098","output_sha256":"56c0f3c3e530406830857e9a9c8e9ee9edfb2a859d4b6c86d493a4910ea14958"}
